News Search Results
Aug 05, 2025, 11:10 ET Electronic Device History Record (eDHR) Software Market Size to Grow USD 642 Million by 2031 at a CAGR of 11.1% | Valuates Reports
pharmaceutical companies continue to adopt eDHR systems to drive efficiency and regulatory success. Tightening global regulations in pharmaceuticals, biotechnology, and life sciences is significantly boosting the demand for eDHR Software. Organizations are under continuous scrutiny to maintain accurate, complete,
More news about: Valuates Reports
Aug 05, 2025, 10:45 ET Cell Culture Market to Reach USD 71.1 Billion by 2032, Says SkyQuest Technology Consulting
Landscapes in Healthcare Red Biotechnology Market - https://www.skyquestt.com/report/red-biotechnology-marketSample Preparation Market -
More news about: SkyQuest Technology
Aug 05, 2025, 10:21 ET With 6.4% CAGR, Extracorporeal CO2 Removal Devices Market to Reach US$184.36 million by 2031 | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Aug 05, 2025, 10:07 ET LexisNexis Recognizes Pivot Bio as One of the World's Ten Most Innovative Biotech Startups
Intellectual Property Solutions as one of the world's ten most innovative biotech startups. The recognition comes from a comprehensive analysis of global biotechnology companies using LexisNexis's proprietary Patent Asset Index, which measures the strength and quality of patent portfolios by combining portfolio
More news about: Pivot Bio, Inc
Aug 05, 2025, 10:01 ET Cardiovascular Echocardiography Market is Expected to Reach US$222.14 Million by 2031 | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Aug 05, 2025, 09:46 ET Future Origins Wins ICIS Innovation Award for Drop-in Replacement Nalo™
energy and raw materials, improved economics, safer performance, and lower environmental impact." Future Origins was founded by industrial biotechnology leader Geno, in partnership with Unilever, Kao, and L'Oréal, to commercialize and manufacture high-volume sustainable ingredients for widely used
More news about: Future Origins
Aug 05, 2025, 09:02 ET Beauty Meets Farming: The Dyson Omega™ Nourishing Collection. Engineered to strengthen hair - for maximum shine
Key features: Nourishes and restores dry, brittle and fragile hair with the Dyson Oli7™ blend.Activated by a biotechnology fermented oil complex to deliver nourishment without weighing down the hair.Enriched with antioxidants and carefully selected ingredients
More news about: Dyson
Aug 05, 2025, 08:30 ET Oncolytics Biotech® Announces Upcoming Annual General Meeting and Second Quarter Financial Results
Meeting as guests but will not be able to vote at the Meeting. About Oncolytics Biotech Inc. Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized
More news about: Oncolytics Biotech® Inc.
Aug 05, 2025, 08:00 ET Ouro Medicines Announces Initiation of OM336 Basket Study in Autoimmune Cytopenias and Granting of U.S. FDA Orphan Drug Designation for OM336 in Autoimmune Hemolytic Anemia (AIHA)
SAN FRANCISCO, Aug. 5, 2025 /PRNewswire/ -- Ouro Medicines, a biotechnology company developing immune reset therapeutics for people living with chronic, immune-mediated diseases, today announced the initiation of a multi-national
More news about: Ouro Medicines
Aug 05, 2025, 08:00 ET iNtRON Bio, Demonstrated Toxin-Neutralizing Effect of IMPA™ Phage Engineering Technology in Colorectal Cancer Model and Completed the US Patent Application
-impa-phage-engineering-technology-in-colorectal-cancer-model-and-completed-the-us-patent-application-302521505.html SOURCE iNtRON Biotechnology, Inc.
More news about: iNtRON Biotechnology, Inc.
Aug 05, 2025, 08:00 ET Curis Provides Second Quarter 2025 Business Update
Mass., Aug. 5, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today reported its financial and
More news about: Curis, Inc.
Aug 05, 2025, 06:50 ET Ascletis Completes Enrollment in U.S. Phase IIa Study for Its Small Molecule Oral GLP-1R Agonist, ASC30, in Participants with Obesity or Overweight
patent protection until 2044 without patent extensions. About Ascletis Pharma Inc. Ascletis Pharma Inc. is a fully integrated biotechnology company focused on the development and commercialization of potential best-in-class and first-in-class therapeutics to treat metabolic diseases.
More news about: Ascletis Pharma Inc.
Aug 05, 2025, 05:12 ET BPC Instruments secures 4.4 MSEK order from a public research organisation in the Philippines
instruments enabling more efficient, reliable, and higher quality research and analysis for industries in renewable bioenergy and environmental biotechnology. The result is not only higher accuracy and precision, but also a significant reduction in time consumption and labor requirement for performing
More news about: BPC Instruments AB
Aug 05, 2025, 05:00 ET Trailhead Biosystems Expands iPSC-Derived Portfolio with TrailBio® Hematopoietic Progenitor Cells
Ohio, Aug. 5, 2025 /PRNewswire/ -- Trailhead Biosystems, Inc. (TrailBio.com), a biotechnology company advancing scalable human cell models derived from induced pluripotent stem cells (iPSCs), announces the commercial release of TrailBio®
More news about: Trailhead Biosystems Inc
Aug 05, 2025, 05:00 ET Trailhead Biosystems Expands iPSC-Derived Portfolio with TrailBio® Hematopoietic Progenitor Cells
Ohio, Aug. 5, 2025 /PRNewswire/ -- Trailhead Biosystems, Inc. (TrailBio.com), a biotechnology company advancing scalable human cell models derived from induced pluripotent stem cells (iPSCs), announces the commercial release of TrailBio®
More news about: Trailhead Biosystems Inc
Aug 05, 2025, 02:17 ET Aquaporin successfully achieves up to 20% energy savings at Kranji NEWater Factory
the United States, and China. We are committed to rethinking water filtration with biotechnology to solve global water challenges. By combining three disciplines from the world of natural sciences: biology, chemistry, and physics, we have created
More news about: Aquaporin A/S
Aug 05, 2025, 02:14 ET Aquaporin successfully achieves up to 20% energy savings at Kranji NEWater Factory
the United States, and China. We are committed to rethinking water filtration with biotechnology to solve global water challenges. By combining three disciplines from the world of natural sciences: biology, chemistry, and physics, we have created
More news about: Aquaporin A/S
Aug 04, 2025, 22:30 ET 180 Life Sciences Closes $425 Million Private Placement to Advance its Ethereum Treasury Strategy
million throughout the coming weeks in addition to continuing its prior legacy iGaming operations, as well as continuing to seek to monetize its biotechnology intellectual property. The Company plans to provide investors with regular updates on its Ethereum holdings to ensure maximum transparency.
More news about: 180 Life Sciences Corp.
Aug 04, 2025, 18:03 ET DEADLINE NEXT WEEK: Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
than Monday, August 11, 2025. CASE ALLEGATIONS: Rocket Pharmaceuticals operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases. The Rocket Pharmaceuticals class action lawsuit
More news about: Robbins Geller Rudman & Dowd LLP
Aug 04, 2025, 16:05 ET INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025
MEETING, Pa., Aug. 4, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancers, and infectious
More news about: INOVIO Pharmaceuticals, Inc.
Aug 04, 2025, 16:02 ET BioMarin Reports Strong Second Quarter 2025 Results and Raises Full-year Guidance¹ for Total Revenues, Non-GAAP Operating Margin, and Non-GAAP Diluted EPS
Conference ID: 6336054 About BioMarin BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The
More news about: BioMarin Pharmaceutical Inc.
Aug 04, 2025, 11:00 ET Medical Device Contract Manufacturing Market to Grow at a CAGR of 11.4% from 2025 to 2032 | SkyQuest Technology Consulting
developed healthcare infrastructure and key biotechnology, and medical device companies help cement the dominance of North America in terms of global demand for medical
More news about: SkyQuest Technology
Aug 04, 2025, 10:30 ET Surgical Instrument Tracking System Market Worth US$751.2 Million by 2030 with 15.2% CAGR | MarketsandMarkets™
integrated tracking solutions. BD serves a wide range of healthcare stakeholders, including hospitals, clinical diagnostic labs, pharmaceutical and biotechnology companies, universities, and government agencies. Its robust presence is supported by a strong distribution network, combining independent channels
More news about: MarketsandMarkets
Aug 04, 2025, 10:15 ET Brachytherapy Devices Market is Growing at CAGR of 6.7% During 2025 -2031 to Reach US$534.20 Million | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Aug 04, 2025, 10:01 ET Cell Culture Market is expected to generate a revenue of USD 93.49 Billion by 2032, Globally, at 14.23% CAGR: Verified Market Research®
ResearchVaccine ProductionToxicity TestingCell Culture Market, by End-user:Pharmaceutical & Biotechnology CompaniesAcademic & Research InstitutesHospitals & Diagnostic LabsCell Culture Market, by Geography
More news about: Verified Market Research